MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance
Advanced Science · 2024
DOI: 10.1002/advs.202308417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Junfeng Xu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroendocrine Tumors, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Hauptthemen laut MEDLINE: beta Catenin, DNA Modification Methylases, DNA Repair Enzymes, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, Scientific Innovation Project of Shanghai Education Committee.
Abstract (Originalsprache)
O6‐methylguanine DNA methyltransferase (MGMT) removes alkyl adducts from the guanine O6 position (O 6 ‐MG) and repairs DNA damage. High MGMT expression results in poor response to temozolomide (TMZ). However, the biological importance of MGMT and the mechanism underlying its high expression in pancreatic neuroendocrine tumors (PanNETs) remain elusive. Here, it is found that MGMT expression is highly elevated in PanNET tissues compared with paired normal tissues and negatively associated with progression‐free survival (PFS) time in patients with PanNETs. Knocking out MGMT inhibits cancer cell growth in vitro and in vivo. Ectopic MEN1 expression suppresses MGMT transcription in a manner that depends on β‐Catenin nuclear export and degradation. The Leucine 267 residue of MEN1 is crucial for regulating β‐Catenin‐MGMT axis activation and chemosensitivity to TMZ. Interference with β‐Catenin re‐sensitizes tumor cells to TMZ and significantly reduces the cytotoxic effects of high‐dose TMZ treatment, and MGMT overexpression counteracts the effects of β‐Catenin deficiency. This study reveals the biological importance of MGMT and a new mechanism by which MEN1 deficiency regulates its expression, thus providing a potential combinational strategy for treating patients with TMZ‐resistant PanNETs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Neuroendocrine Tumors, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
- Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China.
- Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China.
- The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, 213004, China.
ORCID-Profile: Junfeng Xu
Förderung
- National natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
- Scientific Innovation Project of Shanghai Education Committee
- Clinical Research Plan of Shanghai Hospital Development Center
- Xuhui District Artificial Intelligence Medical Hospital Cooperation Project
- Shanghai Municipal Science and Technology Commission
- Shanghai Pujiang Program
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Xu, J., Lou, X., Wang, F., Zhang, W., Xu, X., Ye, Z., Zhuo, Q., Wang, Y., Jing, D., Fan, G., Chen, X., Zhang, Y., Zhou, C., Chen, J., Qin, Y., Yu, X., & Ji, S. (2024). MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance. Advanced Science. https://doi.org/10.1002/advs.202308417
Vancouver
Xu J, Lou X, Wang F, Zhang W, Xu X, Ye Z, et al. MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance. Advanced Science. 2024. doi:10.1002/advs.202308417
BibTeX
@article{Xu2024,
author = {Xu, Junfeng and Lou, Xin and Wang, Fei and Zhang, Wuhu and Xu, Xiaowu and Ye, Zeng and Zhuo, Qifeng and Wang, Yan and Jing, Desheng and Fan, Guixiong and Chen, Xuemin and Zhang, Yue and Zhou, Chenjie and Chen, Jie and Qin, Yi and Yu, Xianjun and Ji, Shunrong},
title = {MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202308417}
}
EUVIMED